Literature DB >> 6271557

Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. II. Blocking studies with monoclonal antibodies to HLA determinants.

L E Wallace, D J Moss, A B Rickinson, A J McMichael, M A Epstein.   

Abstract

Monoclonal antibodies specifically binding common determinants on all HLA-A, B anc C antigen molecules blocked the lysis of EB virus-transformed target cells by EB virus-specific cytotoxic T cells reactivated in vitro. Blocking was mediated through binding of the antibodies to the target rather than to the effector cells and was maximal (75 to 85% inhibition of lysis) at saturating antibody concentrations. A similar blocking effect was also shown by a monoclonal antibody binding to beta 2-microglobulin, a molecule physically associated with HLA-A, B and C antigens on the target cell surface, but not by a monoclonal antibody binding to the non-HLA-associated leukocyte-common antigen. Saturating concentrations of monoclonal antibodies specific for common determinants on all HLA-DRw antigen molecules either had no effect at all upon EB virus-specific T cell cytotoxicity or caused a slight, but nonspecific, inhibition. The results demonstrate unequivocally that HLA-A, B and C antigens on the target cell surface are indeed the polymorphic elements which impose genetic restriction upon EB virus-specific cytotoxic T cell function.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6271557     DOI: 10.1002/eji.1830110905

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  17 in total

1.  In vitro expansion of Epstein-Barr virus-specific HLA-restricted cytotoxic T cells direct from the blood of infectious mononucleosis patients.

Authors:  G Strang; A B Rickinson
Journal:  Immunology       Date:  1987-12       Impact factor: 7.397

2.  Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains.

Authors:  R J Murray; L S Young; A Calender; C D Gregory; M Rowe; G M Lenoir; A B Rickinson
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

3.  Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivity.

Authors:  Nancy H Gudgeon; Graham S Taylor; Heather M Long; Tracey A Haigh; Alan B Rickinson
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  Synovial T lymphocyte recognition of organisms that trigger reactive arthritis.

Authors:  J S Gaston; P F Life; K Granfors; R Merilahti-Palo; L Bailey; S Consalvey; A Toivanen; P A Bacon
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

5.  Bovine cytotoxic T-cell clones specific for cells infected with the protozoan parasite Theileria parva: parasite strain specificity and class I major histocompatibility complex restriction.

Authors:  B M Goddeeris; W I Morrison; A J Teale; A Bensaid; C L Baldwin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

6.  New HLA-A2 variants defined by monoclonal antibodies and cytotoxic T lymphocytes.

Authors:  L J Kennedy; L E Wallace; J A Madrigal; A B Rickinson; J G Bodmer
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

7.  Mutant HLA-A2 antigens as restricting elements for virus-specific cytotoxic T cells.

Authors:  J S Gaston; L E Wallace; A B Rickinson; M A Epstein; D Pious
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

Review 8.  Cell-mediated immunity against Epstein-Barr virus infected B lymphocytes.

Authors:  E Klein; M G Masucci
Journal:  Springer Semin Immunopathol       Date:  1982

9.  Acquired hypogammaglobulinemia following infectious mononucleosis.

Authors:  J F Greally; E Lawlor; J Lyons; A Rickinson; K Sakamoto; D Purtilo
Journal:  J Clin Immunol       Date:  1983-07       Impact factor: 8.317

10.  Expression rate of cytokine mRNA in the liver of chronic hepatitis C: comparison with chronic hepatitis B.

Authors:  R Fukuda; S Satoh; X T Nguyen; Y Uchida; N Kohge; S Akagi; S Ikeda; M Watanabe; S Fukumoto
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.